Clinsight AB
AI platform revolutionizing prostate cancer diagnosis and risk prediction.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2022
- Grundlagt
Nøglebeslutningstagere
Stefan Almestrand
Board executive
Martin Eklund
CEO
Nita Mulliqi
Head of AI
Anna Dimitrova
CFO
+2 flere kontakter i Funnelfeedr
Beskrivelse
Clinsight is a HealthTech company dedicated to revolutionizing clinical decision-making in prostate cancer diagnosis.\nThey have developed ClinAI™, an autonomous AI-powered analysis tool for standard biopsy slides.\nThis technology provides outcome-based risk prediction and precise Gleason scoring,...